Last Updated: June 22, 2026

LABETALOL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Labetalol, and when can generic versions of Labetalol launch?

Labetalol is a drug marketed by Amneal, Apothecon, Baxter Hlthcare Corp, Caplin, Gland Pharma Ltd, Hikma, Hospira, Onesource Specialty, Rising, Aiping Pharm Inc, Andas 5 Holding, Appco, Cadila Pharms Ltd, Epic Pharma Llc, Heritage Pharma, Hibrow Hlthcare, Macleods Pharms Ltd, Ph Health, Rubicon Research, Teva, Unichem, Watson Labs, and Zydus Pharms. and is included in twenty-eight NDAs.

The generic ingredient in LABETALOL is labetalol hydrochloride. There are fourteen drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the labetalol hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Labetalol

A generic version of LABETALOL was approved as labetalol hydrochloride by HERITAGE PHARMA on August 3rd, 1998.

  Start Trial

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for LABETALOL?
  • What are the global sales for LABETALOL?
  • What is Average Wholesale Price for LABETALOL?

US Patents and Regulatory Information for LABETALOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Macleods Pharms Ltd LABETALOL HYDROCHLORIDE labetalol hydrochloride TABLET;ORAL 217949-001 Sep 23, 2025 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Epic Pharma Llc LABETALOL HYDROCHLORIDE labetalol hydrochloride TABLET;ORAL 212990-002 Sep 30, 2020 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Rubicon Research LABETALOL HYDROCHLORIDE labetalol hydrochloride TABLET;ORAL 211953-003 Aug 18, 2021 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Zydus Pharms LABETALOL HYDROCHLORIDE labetalol hydrochloride TABLET;ORAL 207743-002 Sep 19, 2017 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Ph Health LABETALOL HYDROCHLORIDE labetalol hydrochloride TABLET;ORAL 200908-002 Jul 10, 2012 AB RX No Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Teva LABETALOL HYDROCHLORIDE labetalol hydrochloride TABLET;ORAL 074989-001 Sep 30, 1998 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.